No takes yet. Share an insight, caveat, or question.
Clinical review reveals variable efficacy and notable tolerance from intraspinal morphine in cancer pain, indicating technical and pharmacological barriers to widespread use.
Ventafridda et al. (1987) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: